Effectiveness of dapagliflozin versus comparators on renal endpoints in the real world: A multicentre retrospective study-Reference-Cited by-同舟云学术

Effectiveness of dapagliflozin versus comparators on renal endpoints in the real world: A multicentre retrospective study

Published:2018-09-21 Issue:2 Volume:21 Page:252-260
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Fadini Gian Paolo¹^ORCID,Solini Anna²^ORCID,Manca Maria Laura³,Penno Giuseppe³,Gatti Adriano⁴,Anichini Roberto⁵,Del Prato Stefano³^ORCID,Avogaro Angelo¹^ORCID,

Affiliation:

1. Department of Medicine; University of Padova; Padova Italy

2. Department of Surgical, Medical, Molecular and Critical Area Pathology; University of Pisa; Pisa Italy

3. Department of Clinical and Experimental Medicine; University of Pisa; Pisa Italy

4. Metabolic Disease Unit, San Gennaro Hospital; Naples Italy

5. Diabetes Unit, Department of Internal Medicine; San Jacopo Hospital; Pistoia Italy

Funder

Italian Diabetes Society

AstraZeneca

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.13508/fullpdf

Reference35 articles.

1. Continued efforts to translate diabetes cardiovascular outcome trials into clinical practice;Avogaro;Cardiovasc Diabetol,2016

2. Canagliflozin and cardiovascular and renal events in type 2 diabetes;Neal;N Engl J Med,2017

3. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N Engl J Med,2015

4. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes;Marso;N Engl J Med,2016

5. Liraglutide and cardiovascular outcomes in type 2 diabetes;Marso;N Engl J Med,2016

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective analysis of the effect of SGLT-2 inhibitors on renal function in patients with type 2 diabetes in the real world;Frontiers in Pharmacology;2024-08-05

2. A review of the latest real‐world evidence studies in diabetic kidney disease: What have we learned about clinical practice and the clinical effectiveness of interventions?;Diabetes, Obesity and Metabolism;2024-06-20

3. The association between sodium glucose cotransporter‐2 inhibitors vs dipeptidyl peptidase‐4 inhibitors and renal outcomes in people discharged from hospital with type 2 diabetes: A population‐based cohort study;Journal of Diabetes;2024-04

4. Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk;The Lancet Regional Health - Europe;2024-03

5. The Role of Sodium-Glucose Cotransporter-2 Inhibitors in the Treatment Paradigm of CKD in Africa: An African Association of Nephrology Panel Position Paper;Kidney International Reports;2023-12